HIGHLIGHTS
- who: Jie Qiu and colleagues from the Second Clinical College, Zhejiang Chinese Medical University, Hangzhou, China have published the Article: Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real- World Data, in the Journal: Journal of Oncology
- how: Data were analyzed with the IBM SPSS statistics software version 25 (SPSS Inc []. Survival curves for DFS and OS based on the axillary pathological nodal status after NAC are shown in OR=odds ratio CI=confdence interval REF=reference HER2=human epidermal growth factor receptor 2 LVI=lymphovascular invasion. * Only patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.